约翰·霍普金斯的研究人员创造了人工智能血液测试 快速测量了胰腺癌治疗的功效 Johns Hopkins researchers create AI blood test that swiftly gauges pancreatic cancer treatment efficacy.

约翰·霍普金斯的研究人员开发了人工智能血液测试,名为ARTEMIS-DELFI,可以迅速确定胰腺癌治疗的有效性。 Researchers at Johns Hopkins have developed an AI blood test called ARTEMIS-DELFI that can quickly determine the effectiveness of pancreatic cancer treatments. 测试分析血液中的DNA碎片,发现比传统成像和临床标记更能预测治疗结果。 The test analyzes DNA fragments in the blood and was found to be more predictive of treatment outcomes than traditional imaging and clinical markers. 这将使医生能够更迅速地调整治疗方法,以取得更好的患者结果。 This could allow doctors to adjust treatments more promptly for better patient outcomes. 进一步的研究将探讨其在其他癌症中的用途。 Further studies will explore its use in other cancers.